A small-cap biotechnology company focused on developing therapeutics and research platforms using 3D bioprinting technology to create functional human tissues. Its programs have centered on liver disease treatments and engineered tissue models used in drug discovery and toxicology testing. Investors...
1 member of Congress has disclosed 1 trade in Organovo Holdings, Inc. (ONVO), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2014-11-06 | WILLIAM L. OWENS | buy | $1K – $15K |